Valeant Pharmaceuticals International Inc $135.41

down 0.00


22/4/2014 06:40 PM  |  NYSE : VRX  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get VRX Trend Analysis - it has outperformed the S&P 500 by 62%

Partner Headlines

  1. Big Pharmas Swap Specialties

    IBD
  2. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  3. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  4. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  5. Jeff Ubben on Valeant and Microsoft

    GuruFocus
  6. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  7. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  8. Ackman: No Laws Broken in Allergan Buy

    FoxBusiness
  9. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  10. Mid-Afternoon Market Update: Revance Therapeutics Continues to Rally as ...

    Benzinga
  11. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  12. Nasdaq, Health Care Lead Stock Market Higher

    IBD
  13. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  14. Valeant Bid For Allergan Draws Mixed Reaction

    IBD
  15. Mid-Day Market Update: Allergan Surges On Buyout Offer; Lexmark Shares ...

    Benzinga
  16. UPDATE: Allergan Confirms Receipt of Unsolicited Proposal from Valeant, ...

    Benzinga
  17. Mid-Morning Market Update: Markets Gain; McDonald's Posts Lower Profit

    Benzinga
  18. Stocks Power Out Early Gains; Allergan Leads Drug-Maker Surge

    IBD
  19. Stocks Hitting 52-Week Highs

    Benzinga
  20. Morning Market Movers

    Benzinga
  21. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  24. ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, ...

    Benzinga
  25. UPDATE: Valeant Proposes to Combine with Allergan at $48.30/Cash, 0.83 ...

    Benzinga
  26. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  27. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  28. Benzinga's M&A Chatter for Monday April 21, 2014

    Benzinga
  29. Valeant, Ackman Eye Allergan

    IBD
  30. Allergan and Valeant Rally on News of Potential Three Way Deal With Pershing ...

    Benzinga
  31. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  32. Pershing, Valeant Team Up in Bid to Buy Allergan

    FoxBusiness
  33. Facebook, Walgreen Climb Monday On International News

    IBD
  34. Nasdaq Finishes Near 4000 Level In Another Sell-Off

    IBD
  35. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  36. Ethical Drug Stocks Are Struggling

    IBD
  37. IBD 50 Stocks Fade With Market; Some Trip Sell Rules

    IBD
  38. Top Guru-Held Canadian Stocks

    GuruFocus
  39. Drug, Airline Stocks Top Shortened Weekly Review

    IBD
  40. Selling Pressure Builds In Leading Growth Stocks, Nasdaq

    IBD
  41. Top Industry Groups Take Big Hits In Market Sell-Off

    IBD
  42. 'We do not rely on Wall Street-generated research' - A Look at Former Buffett ...

    GuruFocus
  43. Biotechs, Medicals Get Hurt Amid Price-Inquiry News

    IBD
  44. Tableau, Vertex, Wynn Setting Up Follow-On Buy Areas

    IBD
  45. Tableau, Vertex, Wynn Setting Up Follow-On Buy Areas

    IBD
  46. Gentherm, Kors Setting Up in Tight Formations

    IBD
  47. Leaders Finding Support As Market Takes A Breather

    IBD
  48. Three Leading Growth Names Pull Back To Key Support Level

    IBD
  49. Valeant Pharmaceuticals Hit By Budget Tax Clause

    IBD
  50. Highflying Drug, Biotech Stocks Take Rare Drubbing

    IBD
Trading Center